Why I Believe the Resmed Share Price Should Be 18% Higher
Investing in stocks often involves navigating fluctuations in share prices, but a rising share price doesn't necessarily mean a company has lost its value. Resmed CDI ( ASX: RMD ) serves as a prime example of this principle, with its share price making a notable recovery since its October 2023 lows. Despite the significant uptick, there's still ample potential for further gains. Image Credit: Pexels Resmed's Impressive Recovery Resmed, a prominent provider of respiratory devices for treating obstructive sleep apnea (OSA), has experienced a remarkable resurgence in its share price. From its lowest point in October 2023 at $21.14, the company's shares have surged by 41% to reach their current level of $29.90. Additionally, Resmed is an ASX healthcare stock . Valuation and Growth Prospects While Resmed shares may no longer be trading at bargain basement prices, with a price-to-earnings (P/E) ratio of 32 times FY2024 earnings, the company remains in line with the global me...